Health Ministry OPD platform eSanjeevani completes 3 lakh teleconsultations

eSanjeevani OPD services have enabled patient-to-doctor telemedicine in midst of the COVID-19 pandemic.

Published On 2020-09-25 03:30 GMT   |   Update On 2020-09-25 03:30 GMT

New Delhi: eSanjeevani OPD platform of the Ministry of Health and Family Welfare has completed 3 lakh teleconsultations. This landmark milestone has been achieved within a short period of six months since its launch.eSanjeevani OPD services have enabled patient-to-doctor telemedicine in midst of the COVID-19 pandemic. This has helped in containing the spread of COVID by ensuring...

Login or Register to read the full article

New Delhi: eSanjeevani OPD platform of the Ministry of Health and Family Welfare has completed 3 lakh teleconsultations. This landmark milestone has been achieved within a short period of six months since its launch.

eSanjeevani OPD services have enabled patient-to-doctor telemedicine in midst of the COVID-19 pandemic. This has helped in containing the spread of COVID by ensuring physical distancing and has simultaneously enabled provisions for non-COVID essential healthcare. The number of high teleconsultations is a testimony of its popularity among the citizens.

Also Read: Dr Harsh Vardhan lauds contribution of States in popularising eSanjeevani, the Tele-Medicine platform of Health Ministry

With 1,29,801 digital interactions, Tamil Nadu has held the largest number of teleconsultation so far. Tamil Nadu had been a pioneer in the field registering 32,035 OPD consultations by 9th August and 56,346 consultations by the 19th of the same month. The State had registered nearly one lakh consultations (97,204) by 8th September. The platform had provided essential healthcare to the State, one of the worst affected by COVID-19, at a critical time when conventional medicine was perceived to be risky owing to the nature of the infectious disease.

Tami Nadu is followed by Uttar Pradesh (96,151 consultations), Kerala (32,921 consultations) and Uttarakhand (10,391 consultations). These four States account for 2,69,264 tele-consultations (89.75% of total consultations).



With the onboarding of Gujarat and UT of Jammu and Kashmir on eSanjeevaniOPD and Chhattisgarh on eSanjeevani (AB-HWC) the total no. of States and UTs using eSanjeevani has gone up to 26. Around 4,600 doctors have been trained on eSanjeevaniOPD and on an average over 6000 consultations/day are recorded in eSanjeevani's national network.

The aspect that makes the eSanjeevani telemedicine platform special is that the Operations and Management of the platform have been organized in a very methodological manner. A close and efficient connection is maintained between the States and the implementing agency (C-DAC Mohali). This enables quick feedback from the users which helps the implementing team to make quick optimizations. Accordingly, eSanjeevani is not only consistently increasing with respect to its efficiency/productivity but it is also getting enriched with newer functionalities and features as required by the users in the States.

eSanjeevani platform has enabled two types of telemedicine services viz. Doctor-to-Doctor (eSanjeevani) and Patient-to-Doctor (eSanjeevani OPD) Tele-consultations. The former is being implemented through Ayushman Bharat Health and Wellness Centre (AB-HWC). It aims to implement teleconsultation in all 1.5 lakh HWCs in conjunction with identified Medical College hospitals in a 'Hub and Spoke' model. States have identified and set up dedicated 'Hubs' in Medical Colleges and District hospitals to provide teleconsultation services to 'Spokes', i.e SHCs, PHCs and HWCs.

Health Ministry rolled out the second teleconsultation service 'eSanjeevani OPD' enabling patient-to-doctor telemedicine owing to the COVID-19 pandemic in April 2020. This has proved a boon in containing the spread of COVID while simultaneously enabling provisions for non-COVID essential healthcare.

Also Read:Govt telemedicine service platform eSanjeevani records 3 lakh teleconsultations

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News